Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DISHMAN PHARMA BIOCON /
DISHMAN PHARMA
 
P/E (TTM) x 36.9 30.0 122.9% View Chart
P/BV x 4.1 3.3 123.7% View Chart
Dividend Yield % 0.2 0.7 26.5%  

Financials

 BIOCON    DISHMAN PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-22
DISHMAN PHARMA
Mar-16
BIOCON /
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs424374 113.3%   
Low Rs315129 244.3%   
Sales per share (Unadj.) Rs68.2197.0 34.6%  
Earnings per share (Unadj.) Rs8.221.2 38.5%  
Cash flow per share (Unadj.) Rs14.934.7 43.0%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Avg Dividend yield %0.10.8 17.0%  
Book value per share (Unadj.) Rs68.5179.9 38.1%  
Shares outstanding (eoy) m1,200.6080.70 1,487.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.41.3 424.4%   
Avg P/E ratio x45.311.9 381.8%  
P/CF ratio (eoy) x24.77.3 341.3%  
Price / Book Value ratio x5.41.4 385.4%  
Dividend payout %6.19.4 65.0%   
Avg Mkt Cap Rs m443,62220,307 2,184.5%   
No. of employees `000NANA-   
Total wages/salary Rs m18,8015,355 351.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,84015,898 514.8%  
Other income Rs m6,891265 2,596.5%   
Total revenues Rs m88,73116,163 549.0%   
Gross profit Rs m13,8274,103 337.0%  
Depreciation Rs m8,1421,091 746.6%   
Interest Rs m676944 71.6%   
Profit before tax Rs m11,9002,334 509.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,115624 339.2%   
Profit after tax Rs m9,7851,710 572.2%  
Gross profit margin %16.925.8 65.5%  
Effective tax rate %17.826.7 66.5%   
Net profit margin %12.010.8 111.2%  
BALANCE SHEET DATA
Current assets Rs m83,82311,018 760.8%   
Current liabilities Rs m38,2809,517 402.2%   
Net working cap to sales %55.69.4 589.4%  
Current ratio x2.21.2 189.1%  
Inventory Days Days10157 176.5%  
Debtors Days Days923 2,624.6%  
Net fixed assets Rs m117,18418,787 623.7%   
Share capital Rs m6,003161 3,719.3%   
"Free" reserves Rs m76,28114,354 531.4%   
Net worth Rs m82,28414,516 566.9%   
Long term debt Rs m39,9854,189 954.4%   
Total assets Rs m201,00729,805 674.4%  
Interest coverage x18.63.5 536.0%   
Debt to equity ratio x0.50.3 168.4%  
Sales to assets ratio x0.40.5 76.3%   
Return on assets %5.28.9 58.4%  
Return on equity %11.911.8 100.9%  
Return on capital %10.317.5 58.7%  
Exports to sales %024.9 0.0%   
Imports to sales %7.83.7 207.9%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m6,360594 1,070.2%   
Fx inflow Rs m8,8854,952 179.4%   
Fx outflow Rs m6,360697 912.9%   
Net fx Rs m2,5254,255 59.3%   
CASH FLOW
From Operations Rs m11,7662,786 422.3%  
From Investments Rs m-16,991-1,529 1,111.3%  
From Financial Activity Rs m2,421-941 -257.3%  
Net Cashflow Rs m-2,433317 -768.7%  

Share Holding

Indian Promoters % 39.7 61.4 64.6%  
Foreign collaborators % 21.0 0.0 -  
Indian inst/Mut Fund % 23.6 23.0 102.6%  
FIIs % 15.8 12.0 131.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 38.6 102.0%  
Shareholders   369,816 52,291 707.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Biocon vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs Dishman Pharma Share Price Performance

Period Biocon Dishman Pharma S&P BSE HEALTHCARE
1-Day -0.63% 2.87% -0.10%
1-Month 5.56% -2.45% -1.99%
1-Year -22.75% 96.38% -5.62%
3-Year CAGR -0.26% 50.28% 20.96%
5-Year CAGR -11.19% 41.17% 11.47%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.1%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of Biocon, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.